Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by langostaon May 24, 2018 1:43pm

115 Views

Post# 28076374

RE:RE:RE:RE:RE:RE:RE:RE:RE:New investor

By the time this company is through Phase2 it will probably be part of Merck or some other big pharma.

Phase II

Phase II trials test whether a drug or other treatment is effective against a specific type of cancer based on the dose and schedule determined to be safe in a phase I trial. Phase II trials may also compare different schedules of giving the treatment. Researchers study a drug or treatment in a relatively small group of people (usually less than 100) with one type of cancer. Most participants in phase II trials have not responded well to standard treatment or do not have a standard treatment available to them.

Phase II trials:

try to get a better idea of how effective a treatment is for a certain type of cancer
continue to evaluate how safe the drug is and what effect it has on the body

Bullboard Posts

Eminent acquires promising Nevada gold project